Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-27 @ 10:40 PM
Study NCT ID:
NCT00807261
Status:
UNKNOWN
Last Update Posted:
2008-12-12
First Post:
2008-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy
Sponsor:
Asan Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2010-09
Completion Date Type:
ESTIMATED
First Submit Date:
2008-12-10
First Submit QC Date:
None
Study First Post Date:
2008-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-12-11
Last Update Post Date:
2008-12-12
Last Update Post Date Type:
ESTIMATED